Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Theravance Biopharma, Inc. - Ordinary Shares
(NQ:
TBPH
)
18.94
-0.24 (-1.25%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Theravance Biopharma, Inc. - Ordinary Shares
< Previous
1
2
3
4
5
6
Next >
Stay updated with the stocks that are on the move in today's pre-market session.
↗
January 26, 2026
Via
Chartmill
These stocks that are showing activity before the opening bell on Friday.
↗
January 23, 2026
Via
Chartmill
These stocks that are showing activity before the opening bell on Tuesday.
↗
January 13, 2026
Via
Chartmill
Millrose Properties Stock Has Surged 48% Since February Debut — So Why Did One Investor Sell a $23 Million Stake?
↗
December 07, 2025
A newly public real-estate platform is putting up numbers that look far more seasoned than its age.
Via
The Motley Fool
Topics
Regulatory Compliance
Earnings Scheduled For November 10, 2025
↗
November 10, 2025
Via
Benzinga
Earnings Scheduled For May 8, 2025
↗
May 08, 2025
Via
Benzinga
Earnings Scheduled For February 26, 2025
↗
February 26, 2025
Via
Benzinga
Earnings Scheduled For November 12, 2024
↗
November 12, 2024
Via
Benzinga
Unveiling 4 Analyst Insights On Theravance Biopharma
↗
September 16, 2024
Via
Benzinga
Why One Investor Bought $67.5 Million in Array Digital Infrastructure Stock
↗
December 07, 2025
One fund just made a bold bet on a telecom stock undergoing a big transformation
Via
The Motley Fool
Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surge
↗
December 07, 2025
This fund just doubled down on a stock that’s suddenly delivering the earnings momentum it’s promised for years.
Via
The Motley Fool
Topics
Regulatory Compliance
Why One Value Fund Just Bought $30 Million of a Diagnostics Stock Down 90% From Pandemic-Era Highs
↗
December 07, 2025
A beaten-down diagnostics stock is quietly tightening margins and drawing fresh institutional conviction—here’s what that means for long-term investors.
Via
The Motley Fool
Cracking The Code: Understanding Analyst Reviews For Theravance Biopharma
↗
August 06, 2024
Via
Benzinga
Recap: Theravance Biopharma Q4 Earnings
↗
February 26, 2024
Via
Benzinga
Top movers analysis one hour before the close of the markets on 2025-11-11: top gainers and losers in today's session.
↗
November 11, 2025
Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
Here's Why Shares in Theravance Biopharma Exploded Today
↗
November 11, 2025
The company is making excellent progress on all its strategic goals.
Via
The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
November 11, 2025
Via
Benzinga
Theravance Biopharma Inc (NASDAQ:TBPH) Reports Q3 2025 Earnings Beat Amid Muted Market Reaction
↗
November 10, 2025
Theravance Biopharma (TBPH) reported Q3 2025 results, beating EPS estimates with a profit of $0.04. Revenue was slightly below forecasts. Lead drug YUPELRI achieved record sales.
Via
Chartmill
Topics
Earnings
PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
October 21, 2025
Via
Benzinga
Why Crown Holdings Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
↗
October 21, 2025
Via
Benzinga
This Protagonist Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday
↗
September 12, 2025
Via
Benzinga
Theravance Sales Jump 83 Percent
↗
August 12, 2025
Via
The Motley Fool
Theravance Biopharma Inc (NASDAQ:TBPH) Misses Q2 2025 Revenue and EPS Estimates Amid Mixed Market Reaction
↗
August 12, 2025
Theravance Biopharma (TBPH) Q2 2025 earnings missed revenue and EPS estimates, but stock rose 3.1% after-hours. Focus remains on YUPELRI and Ampreloxetine pipeline.
Via
Chartmill
Topics
Earnings
This Coinbase Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
↗
June 17, 2025
Via
Benzinga
TBPH Stock Earnings: Theravance Biopharma Beats EPS, Misses Revenue for Q2 2024
↗
August 05, 2024
TBPH stock results show that Theravance Biopharma beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Mama's Creations, GameStop And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
↗
June 12, 2024
Via
Benzinga
Earnings Scheduled For August 12, 2025
↗
August 12, 2025
Via
Benzinga
TBPH Stock Earnings: Theravance Biopharma Beats EPS, Beats Revenue for Q1 2024
↗
May 13, 2024
TBPH stock results show that Theravance Biopharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
BTIG Research Predicts Over 118% Rally for These 3 Stocks
↗
April 15, 2024
Wall Street stock predictions can run wild but after the tech sector's gains, these stocks could be better places for your money.
Via
InvestorPlace
Short-Squeeze Showdown: 3 Stocks Ready to Crush the Skeptics
↗
March 12, 2024
Although the bears see cynical opportunities, you can make give them a taste of their own medicine with these short-squeeze stocks.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
